AVY
47
-7
EQIX
64
5
C
82
3
BK
74
5
AMAT
52
3
CCI
36
2
AIZ
78
2
APA
53
5
CFG
95
2
ALL
56
2
BAC
77
5
ADM
47
2
CRM
70
18
AIG
77
2
CHRW
82
3
CNX
49
3
CME
45
3
VIX
22
-14
CA
30
3
BF.B
48
-2
AVY
47
-7
EQIX
64
5
C
82
3
BK
74
5
AMAT
52
3
CCI
36
2
AIZ
78
2
APA
53
5
CFG
95
2
ALL
56
2
BAC
77
5
ADM
47
2
CRM
70
18
AIG
77
2
CHRW
82
3
CNX
49
3
CME
45
3
VIX
22
-14
CA
30
3
BF.B
48
-2
Financhill
Back

Vanguard S&P Mid-Cap 400 Value Index Fund ETF Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison

Buy
69

IVOV
Vanguard S&P Mid-Cap 400 Value Index Fund ETF

Last Price:
$104.11
Seasonality Move:
4.79%
Sell
44

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$112.11
Seasonality Move:
-13.08%
Buy
69
Vanguard S&P Mid-Cap 400 Value Index Fund ETF (IVOV) is a Buy

Is Vanguard S&P Mid-Cap 400 Value Index Fund ETF a Buy, Sell or Hold?

  • The current Vanguard S&P Mid-Cap 400 Value Index Fund ETF [IVOV] share price is $104.16. The Score for IVOV is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • IVOV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Rhythm Pharmaceuticals, Inc. (RYTM) is a Sell

Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $111.73. The Score for RYTM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IVOV Stock Price Chart

What is Vanguard S&P Mid-Cap 400 Value Index Fund ETF's stock price today?

  • The Vanguard S&P Mid-Cap 400 Value Index Fund ETF share price today is $104.16
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IVOV is experiencing buying pressure, which is a positive indicator for future bullish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals, Inc.'s stock price today?

  • The Rhythm Pharmaceuticals, Inc. share price today is $111.73
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.

IVOV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.07 Buy
Relative Strength Index (14 RSI): 60.91 Buy
Chaikin Money Flow: 7215 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 15.8 Buy
Relative Strength Index (14 RSI): 56.8 Buy
Chaikin Money Flow: 32783 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

IVOV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.14 Buy
20-day SMA: 102.69 Buy
50-day SMA: 100.74 Buy
200-day SMA: 96.35 Buy
8-day EMA: 103.7 Buy
20-day EMA: 102.7 Buy
50-day EMA: 101.35 Buy
200-day EMA: 98.1 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 110.65 Buy
20-day SMA: 107.3 Buy
50-day SMA: 106.17 Buy
200-day SMA: 82.91 Buy
8-day EMA: 44.16 Buy
20-day EMA: 20.28 Buy
50-day EMA: 8.6 Buy
200-day EMA: 2.21 Buy

Vanguard S&P Mid-Cap 400 Value Index Fund ETF Earnings Growth & IVOV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.47 per share.

Vanguard S&P Mid-Cap 400 Value Index Fund ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):